486P Bioavailability and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas

Autor: Cassier, P.A., Bendjama, K., Garcia, V. Moreno, De Speville Uribe, B. Doger, Calvo, E., de Miguel, M.J., Jungels, C., Erbs, P., Carpentier, D., Sadoun, A.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S572-S573
Databáze: ScienceDirect